Vaccines
Covid-19 Impact on Bioprocessing: PART 2 Fears to Be Addressed due to Covid-19
The views and opinions expressed in this blog / article are those of the authors and do not…
Ronald Rader
Ronald A. Rader is the Senior Director, Technical Research, BioPlan Associates. He has 35+ years’ experience as a biotechnology and pharmaceutical, particularly biopharmaceutical, information specialist, analyst and publisher, and has been responsible for the Antiviral Agents Bulletin periodical; Federal Bio-Technology Transfer Directory; BIOPHARMA: Biopharmaceutical Products in the U.S. and European Market; and the Biosimilars/Biobetters Pipeline Directory
